Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Vaccines in RA Patients on Tofacitinib
NCT01359150Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tofacitinib in rheumatoid arthritis (RA), sponsored by Pfizer. Started Sep 2011; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01359150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01359150.